What does Aphranel EU MDR certification mean for Moyom’s European expansion?
Moyom links Aphranel EU MDR certification with Expert2Expert research and training as it prepares for European regenerative aesthetics expansion.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Navi has FDA clearance and A$6.8m. Can Neonav turn neonatal catheter guidance into a U.S. hospital business?
Navi raises A$6.8 million to launch FDA-cleared Neonav in U.S. hospitals, targeting safer neonatal and paediatric vascular access.
Medical Devices & Diagnostics
LyoGenesis Plus and Wynn Pharmaceuticals join Vector in critical-care manufacturing plan
Vector, LyoGenesis Plus and Wynn plan IV bag and vial adapter products, but definitive agreements and regulatory pathways remain ahead.
Medical Devices & Diagnostics
How EvoEndo plans to scale sedation-free endoscopy beyond academic medical centers
EvoEndo is widening sedation-free endoscopy access, but training, reimbursement and workflow will decide whether adoption scales.
Medical Devices & Diagnostics
Epitel’s $26m bet could take weeks-long wireless EEG monitoring beyond specialist centres
Epitel’s $26 million Series B will expand REMI wireless EEG monitoring, provider adoption and ambulatory seizure detection across the United States.
Medical Devices & Diagnostics
How the Nexus acquisition of Telemetrix RPM could reshape hospital-to-home care
Nexus acquires Telemetrix RPM to link virtual nursing, remote monitoring and chronic care while facing major integration and reimbursement tests.
Medical Devices & Diagnostics
Can Seegene’s million-case GMCS establish a new standard for HPV and STI testing?
Seegene will test whether combined HPV and STI PCR panels can improve reproductive infection care through its million-case GMCS.
Medical Devices & Diagnostics
Why American Industrial Partners paid $1.27bn for Avanos Medical
American Industrial Partners completes its $1.27 billion Avanos Medical acquisition, taking the medtech company private to accelerate growth and execution.
Medical Devices & Diagnostics
How could CyPath Lung fit into pulmonary nodule evaluation after low-dose CT screening?
bioAffinity’s CyPath Lung framework targets pulmonary nodule decisions, but adoption still depends on prospective validation and payer support.
Medical Devices & Diagnostics
Why the new AHF and PAHO HIV partnership faces a harder challenge than expanding testing
AHF and PAHO will expand early HIV testing and linkage to care as late diagnosis continues to drive preventable deaths across the region.